Smith & Nephew Surgical Implants (Beijing) Co., Ltd.

Smith & Nephew Surgical Implants (Beijing) Co., Ltd. was established in 1995. The company was invested by the Swiss company Plus Surgical Implants and was the first Sino-foreign joint venture in the field of artificial joint production in China, specializing in the production and sales of high-quality hip, knee, spinal and other surgical implants and supporting surgical instruments. Since the company's establishment, new technologies and new production processes have emerged at the company every year. In August 2005, while celebrating the company's tenth anniversary, Plus China became a wholly-owned subsidiary of the Plus Orthopedics Group, transforming from a Sino-foreign joint venture into a wholly foreign-owned company.
In June 2007, the Swiss company Plus Surgical Implants merged with Smith & Nephew, a leading multinational medical products company. The two companies shared the same aspirations in many respects, both committed to innovation and the production of high-quality products. After the merger, the company became the fourth largest company in the global industry. More competitive, it became one of the companies worldwide offering the most comprehensive range of joint reconstruction products, further consolidating Smith & Nephew's position in Europe and advancing the company's development plans in China. In 2007, it built a new orthopedic products factory in Beijing and invested in a new advanced wound care products factory in Suzhou. The company's R&D, manufacturing, sales and marketing work in the United States, Europe and Asia will also develop in a balanced manner.
Smith & Nephew was founded in 1856 by Thomas John Smith, a professional British pharmacist, in Hull in northern England, with its headquarters in London, UK. Through 150 years of continuous effort, Smith & Nephew has developed into a leading multinational medical products company. It holds a leading position in the global medical and health care field. Its business spans 34 countries, the group produces more than 1,400 categories of products, and sales reach as many as 100 countries, making it a highly reputable leader in the industry. Four major product lines among its products: orthopedic reconstruction, endoscopy, advanced wound care series, etc., are all leaders in the global industry. Smith & Nephew is also one of the world's largest manufacturers of dressing products, with a 150-year history of development, providing the most advanced technology and product support in dressings, and with global professional membership qualifications, providing professional training to physicians and helping to enhance the professional standards of end hospitals and physicians. In 1994, Smith & Nephew entered China, with its headquarters in Shanghai, and successively set up offices in Beijing, Guangzhou, Hong Kong, Chongqing and other places. In 1999, Smith & Nephew established its first wholly-owned subsidiary in China in the Shanghai Waigaoqiao Free Trade Zone — Smith & Nephew Medical (Shanghai) Limited. It has distribution institutions in major cities across the country.